BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2126197)

  • 1. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.
    Hunt K; Vessey M; McPherson K
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1080-6. PubMed ID: 2126197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy.
    Hunt K; Vessey M; McPherson K; Coleman M
    Br J Obstet Gynaecol; 1987 Jul; 94(7):620-35. PubMed ID: 3620411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
    BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality of doctors in different specialties: findings from a cohort of 20000 NHS hospital consultants.
    Carpenter LM; Swerdlow AJ; Fear NT
    Occup Environ Med; 1997 Jun; 54(6):388-95. PubMed ID: 9245944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales.
    McMenamin Ú; Hicks B; Hughes C; Murchie P; Hippisley-Cox J; Ranger T; Coupland C; Cardwell C
    BMC Cancer; 2021 Mar; 21(1):313. PubMed ID: 33761919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [State of health of populations residing in geothermal areas of Tuscany].
    Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
    Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V;
    Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy: patterns of use studied through British general practice computerized records.
    Lawrence M; Jones L; Lancaster T; Daly E; Banks E
    Fam Pract; 1999 Aug; 16(4):335-42. PubMed ID: 10493702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.